Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome
NCT ID: NCT03871192
Last Updated: 2019-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2018-08-15
2020-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-Guided Thermocoagulation of Medial Nerve Branch in Lumbar Facet Joints Pain.
NCT03564418
The Specificity of Cervical Facet Medial Branch Blocks
NCT00613340
Comparison of the Effectiveness of Ultrasound-guided Versus Radioguided Medial Lumbar Bundle Branch Block
NCT04658953
Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block
NCT02737527
Analgesic Effect of Different Positions and Canulae on Medial Branch Radiofrequency Denervation for Lumbar Zygapophyseal Joint Pain
NCT03491618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Facet syndrome treatment is also controversial and, although most clinical guidelines recommend nerve block as a diagnostic test, followed by neurolysis as therapeutic technique, there are many detractors of this therapeutic sequence.
The confusion is even greater when considering the variability of specialists who perform these techniques, the variability of methods used ranging from blind injections to injections guided by ultrasound, fluoroscopy or CT, or the amount of medication injected.
The investigators have long experience in the percutaneous treatment of pain and in the use of different imaging techniques. Although the investigators objectives are multiple, the main one is to know if there are any difference in the outcome of the facet syndrome treated by intra-articular injections and the block of the medial branch of the dorsal branch of the spinal nerve.
Along with the collaboration of other specialists the investigators want to address secondary objectives such as the usefulness of ultrasound and fluoroscopy in the treatment of facet syndrome and its comparison with those performed under CT guidance that is considered as the standard technique for its greater precision.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FACET JOINT UNDER CT GUIDANCE
Injection of the facet joint under computed tomography guidance
NERVE BLOCK UNDER CT GUIDANCE
injection of triamcinolone around the dorsal ramus under CT guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone in the facet joint under fluoroscopy guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone around the dorsal ramus under fluoroscopy guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
injection of triamcinolone in the facet joint under ultrasound guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
injection of triamcinolone around the dorsal ramus under ultrasound guidance
NERVE BLOCK UNDER CT GUIDANCE
Injection of the nerve under computed tomography guidance
FACET JOINT UNDER CT GUIDANCE
injection of triamcinolone in the facet joint under CT guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone in the facet joint under fluoroscopy guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone around the dorsal ramus under fluoroscopy guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
injection of triamcinolone in the facet joint under ultrasound guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
injection of triamcinolone around the dorsal ramus under ultrasound guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
Injection of the facet joint under fluoroscopy guidance
FACET JOINT UNDER CT GUIDANCE
injection of triamcinolone in the facet joint under CT guidance
NERVE BLOCK UNDER CT GUIDANCE
injection of triamcinolone around the dorsal ramus under CT guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone around the dorsal ramus under fluoroscopy guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
injection of triamcinolone in the facet joint under ultrasound guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
injection of triamcinolone around the dorsal ramus under ultrasound guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
Injection of the nerve under ultrasound guidance
FACET JOINT UNDER CT GUIDANCE
injection of triamcinolone in the facet joint under CT guidance
NERVE BLOCK UNDER CT GUIDANCE
injection of triamcinolone around the dorsal ramus under CT guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone in the facet joint under fluoroscopy guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
injection of triamcinolone in the facet joint under ultrasound guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
injection of triamcinolone around the dorsal ramus under ultrasound guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
Injection of the facet joint under ultrasound guidance
FACET JOINT UNDER CT GUIDANCE
injection of triamcinolone in the facet joint under CT guidance
NERVE BLOCK UNDER CT GUIDANCE
injection of triamcinolone around the dorsal ramus under CT guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone in the facet joint under fluoroscopy guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone around the dorsal ramus under fluoroscopy guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
injection of triamcinolone around the dorsal ramus under ultrasound guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
Injection of the nerve under computed ultrasound guidance
FACET JOINT UNDER CT GUIDANCE
injection of triamcinolone in the facet joint under CT guidance
NERVE BLOCK UNDER CT GUIDANCE
injection of triamcinolone around the dorsal ramus under CT guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone in the facet joint under fluoroscopy guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone around the dorsal ramus under fluoroscopy guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
injection of triamcinolone in the facet joint under ultrasound guidance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FACET JOINT UNDER CT GUIDANCE
injection of triamcinolone in the facet joint under CT guidance
NERVE BLOCK UNDER CT GUIDANCE
injection of triamcinolone around the dorsal ramus under CT guidance
FACET JOINT UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone in the facet joint under fluoroscopy guidance
NERVE BLOCK UNDER FLUOROSCOPY GUIDANCE
injection of triamcinolone around the dorsal ramus under fluoroscopy guidance
FACET JOINT UNDER ULTRASOUND GUIDANCE
injection of triamcinolone in the facet joint under ultrasound guidance
NERVE BLOCK UNDER ULTRASOUND GUIDANCE
injection of triamcinolone around the dorsal ramus under ultrasound guidance
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
3- failure of conservative treatment (pharmacological and physical therapy). 4-Symptoms present more than 3 months
Exclusion Criteria
2. Contraindication for the use of corticosteroid or local anesthetic.
3. Uncontrolled acute or chronic medical illness.
4. Pregnancy or lactation.
5. Presence of inflammatory arthropathy or neuropathy.
6. Wounds or skin lesions in the area.
7. Diabetes mellitus.
8. Psychiatric disorders
9. Refusal to participate in the study.
10. Demonstration by imaging techniques of other causes that could justify the symptomatology.
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Complejo Hospitalario Universitario de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
FERNANDO RUIZ SANTIAGO
PhD, section chief musculoskeletal radiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FERNANDO RUIZSANTIAGO, PhD
Role: PRINCIPAL_INVESTIGATOR
HOSPITAL DE NEURO-TRAUMATOLOGIA GRANADA (VIRGEN DE LAS NIEVES)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complejo Hospitalario Universitario Granada
Granada, SPA, Spain
Hospital Neuro-Traumatologia
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0607-N-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.